Bactericidal efficacy of meropenem in combination with cefmetazole against IMP-producing carbapenem-resistant Enterobacteriaceae
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bactericidal efficacy of meropenem in combination with cefmetazole against IMP-producing carbapenem-resistant Enterobacteriaceae ; volume:12 ; number:1 ; day:9 ; month:11 ; year:2019 ; pages:1-5 ; date:12.2019
BMC Research Notes / Biomed Central; 12, Heft 1 (9.11.2019), 1-5, 12.2019
- Creator
-
Abe, Ryuichiro
Hagiya, Hideharu
Akeda, Yukihiro
Yamamoto, Norihisa
Ishii, Yoshikazu
Tomono, Kazunori
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-019-4779-x
- URN
-
urn:nbn:de:101:1-2020030721043034339788
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abe, Ryuichiro
- Hagiya, Hideharu
- Akeda, Yukihiro
- Yamamoto, Norihisa
- Ishii, Yoshikazu
- Tomono, Kazunori
- SpringerLink (Online service)
Other Objects (12)
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae
The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study
Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
A systematic review and meta-analysis of carbapenem-resistant Enterobacteriaceae in West Africa
Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran
Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai
Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae
The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study
Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
A systematic review and meta-analysis of carbapenem-resistant Enterobacteriaceae in West Africa
Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran
Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai
Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae
The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study
Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
A systematic review and meta-analysis of carbapenem-resistant Enterobacteriaceae in West Africa
Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran
Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai